Revolution Medicines, Inc. Common Stock (RVMD) News
Latest headlines that mention RVMD, newest first · each headline opens the original publisher
- Last price
- $188.12
- Day change
- -6.35%
- Next earnings
- 2026-11-04
RVMD headlines
last 30 daysBiotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. The post Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers appeared first on Investor's Business Daily .
Revolution Medicines' stock is up 330% in a year on drug development progress; you may want to spread your bets with Royalty Pharma instead.
Axsome is generating revenue from approved drugs but missing estimates and widening losses. Revolution Medicines just changed the standard of care for one of the deadliest cancers in existence.
This company has succeeded where many others have failed.
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.
Also mentioned with RVMD
30dHeadlines that tag both tickers
RVMD news alerts
Get an alert by email or push when a new headline mentions RVMD.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.